Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae

ABSTRACT The Klebsiella pneumoniae carbapenem (KPC) β-lactamase occurs in Enterobacteriaceae and can confer resistance to all β-lactam agents including carbapenems. The enzyme may confer low-level carbapenem resistance, and the failure of susceptibility methods to identify this resistance has been reported. Automated and nonautomated methods for carbapenem susceptibility were evaluated for identification of KPC-mediated resistance. Ertapenem was a more sensitive indicator of KPC resistance than meropenem and imipenem independently of the method used. Carbapenemase production could be confirmed with the modified Hodge test.

[1]  John Quale,et al.  Emergence of KPC-Possessing Klebsiella pneumoniae in Brooklyn, New York: Epidemiology and Recommendations for Detection , 2005, Antimicrobial Agents and Chemotherapy.

[2]  S. B. Singer,et al.  Effective cooling allows sonication to be used for liberation of beta-lactamases from gram negative bacteria. , 1989, The Journal of antimicrobial chemotherapy.

[3]  A. Harris,et al.  Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. , 1976, Journal of general microbiology.

[4]  Clinical,et al.  Performance standards for antimicrobial disk susceptibility tests : approved standard , 2006 .

[5]  V. Miriagou,et al.  Imipenem Resistance in a Salmonella Clinical Strain Due to Plasmid-Mediated Class A Carbapenemase KPC-2 , 2003, Antimicrobial Agents and Chemotherapy.

[6]  P. Nordmann,et al.  Plasmid-Mediated Carbapenem-Hydrolyzing β-Lactamase KPC in a Klebsiella pneumoniae Isolate from France , 2005, Antimicrobial Agents and Chemotherapy.

[7]  P. Bradford,et al.  Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  K. Bush,et al.  Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.

[9]  J. Quinn,et al.  First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South America , 2006, Antimicrobial Agents and Chemotherapy.

[10]  D. Yong,et al.  Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  Roberta B. Carey,et al.  Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing , 2006, Emerging infectious diseases.

[12]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[13]  V. Benedí,et al.  Expression of SHV-2 β-Lactamase and of Reduced Amounts of OmpK36 Porin in Klebsiella pneumoniae Results in Increased Resistance to Cephalosporins and Carbapenems , 2002, Antimicrobial Agents and Chemotherapy.

[14]  D. Landman,et al.  Detection of KPC Carbapenem-Hydrolyzing Enzymes in Enterobacter spp. from Brooklyn, New York , 2005, Antimicrobial Agents and Chemotherapy.

[15]  J. Quinn,et al.  First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing β-Lactamase , 2007, Antimicrobial Agents and Chemotherapy.

[16]  T. Gootz,et al.  The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  Neil Woodford,et al.  Outbreak of Klebsiella pneumoniae Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical Center , 2004, Antimicrobial Agents and Chemotherapy.

[18]  R. Goering,et al.  Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. , 2003, The Journal of antimicrobial chemotherapy.

[19]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[20]  K. Bush,et al.  Carbapenem-Resistant Strain of Klebsiella oxytoca Harboring Carbapenem-Hydrolyzingβ -Lactamase KPC-2 , 2003, Antimicrobial Agents and Chemotherapy.

[21]  A. Harris,et al.  Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. , 1976, Journal of general microbiology.

[22]  Ronald N. Jones,et al.  Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005). , 2006, Diagnostic microbiology and infectious disease.

[23]  K. Bush,et al.  Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein , 1997, Antimicrobial agents and chemotherapy.

[24]  M. Ferraro,et al.  Plasmid-Mediated Carbapenem-Hydrolyzing Enzyme KPC-2 in an Enterobacter sp , 2004, Antimicrobial Agents and Chemotherapy.

[25]  N. Hanson,et al.  Detection of Plasmid-Mediated AmpC β-Lactamase Genes in Clinical Isolates by Using Multiplex PCR , 2002, Journal of Clinical Microbiology.

[26]  N. Woodford,et al.  Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. , 2007, International journal of antimicrobial agents.

[27]  Baha Abdalhamid,et al.  Escherichia coli: development of carbapenem resistance during therapy. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Y. Ishii,et al.  Kinetics Study of KPC-3, a Plasmid-Encoded Class A Carbapenem-Hydrolyzing β-Lactamase , 2005, Antimicrobial Agents and Chemotherapy.

[29]  Y. Carmeli,et al.  Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in Israel , 2006, Antimicrobial Agents and Chemotherapy.

[30]  T. Gootz,et al.  High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of blaACT-1 β-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE , 2006, Antimicrobial Agents and Chemotherapy.